Follow-Up Study of Patients Previously Treated With Pimecrolimus Tablets for Atopic Dermatitis

Novartis66 enrolled

Overview

This extension study is being conducted to collect post-treatment safety information on patients who previously participated in the core clinical trial.

Study Type

OBSERVATIONAL

Enrollment

Conditions

Atopic Dermatitis

Eligibility

Sex: ALLMin age: 18 Years

Medical Language ↔ Plain English

Inclusion Criteria: * Consenting patients who participated in the core clinical trial

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.